These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25139462)

  • 1. Novel strategies for preventing diabetes and obesity complications with natural polyphenols.
    Carpene C; Gomez-Zorita S; Deleruyelle S; Carpene MA
    Curr Med Chem; 2015; 22(1):150-64. PubMed ID: 25139462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes.
    Gomez-Zorita S; Belles C; Briot A; Fernández-Quintela A; Portillo MP; Carpéné C
    Phytother Res; 2017 Aug; 31(8):1273-1282. PubMed ID: 28627722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of Resveratrol on Glucose Uptake and Metabolism.
    León D; Uribe E; Zambrano A; Salas M
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice.
    Carpéné C; Gomez-Zorita S; Gupta R; Grès S; Rancoule C; Cadoudal T; Mercader J; Gomez A; Bertrand C; Iffiu-Soltész Z
    Eur J Nutr; 2014 Dec; 53(8):1625-35. PubMed ID: 24531732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells.
    Gomez-Zorita S; Tréguer K; Mercader J; Carpéné C
    J Physiol Biochem; 2013 Sep; 69(3):585-93. PubMed ID: 23315205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of resveratrol in diabetes and obesity associated with insulin resistance.
    Hoca M; Becer E; Vatansever HS
    Arch Physiol Biochem; 2023 Apr; 129(2):555-561. PubMed ID: 33719825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol and diabetes: A critical review of clinical studies.
    Öztürk E; Arslan AKK; Yerer MB; Bishayee A
    Biomed Pharmacother; 2017 Nov; 95():230-234. PubMed ID: 28843911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dietary Antioxidant Piceatannol Inhibits Adipogenesis of Human Adipose Mesenchymal Stem Cells and Limits Glucose Transport and Lipogenic Activities in Adipocytes.
    Carpéné C; Pejenaute H; Del Moral R; Boulet N; Hijona E; Andrade F; Villanueva-Millán MJ; Aguirre L; Arbones-Mainar JM
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol and diabetes: from animal to human studies.
    Szkudelski T; Szkudelska K
    Biochim Biophys Acta; 2015 Jun; 1852(6):1145-54. PubMed ID: 25445538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties.
    Les F; Deleruyelle S; Cassagnes LE; Boutin JA; Balogh B; Arbones-Mainar JM; Biron S; Marceau P; Richard D; Nepveu F; Mauriège P; Carpéné C
    Chem Biol Interact; 2016 Oct; 258():115-25. PubMed ID: 27475863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-diabetic effects of resveratrol.
    Szkudelski T; Szkudelska K
    Ann N Y Acad Sci; 2011 Jan; 1215():34-9. PubMed ID: 21261639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes.
    Szkudelska K; Nogowski L; Szkudelski T
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):17-24. PubMed ID: 19041941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol shows neuronal and vascular-protective effects in older, obese, streptozotocin-induced diabetic rats.
    Phyu HE; Irwin JC; Vella RK; Fenning AS
    Br J Nutr; 2016 Jun; 115(11):1911-8. PubMed ID: 27153202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the efficacy of plant polyphenols.
    Biasutto L; Mattarei A; Sassi N; Azzolini M; Romio M; Paradisi C; Zoratti M
    Anticancer Agents Med Chem; 2014; 14(10):1332-42. PubMed ID: 24975033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol: anti-obesity mechanisms of action.
    Aguirre L; Fernández-Quintela A; Arias N; Portillo MP
    Molecules; 2014 Nov; 19(11):18632-55. PubMed ID: 25405284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms.
    Naz R; Saqib F; Awadallah S; Wahid M; Latif MF; Iqbal I; Mubarak MS
    Molecules; 2023 May; 28(10):. PubMed ID: 37241737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidiabetic therapeutic potential of dietary polyphenols.
    Habtemariam S; Varghese GK
    Curr Pharm Biotechnol; 2014; 15(4):391-400. PubMed ID: 24938887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol Anti-Obesity Effects: Rapid Inhibition of Adipocyte Glucose Utilization.
    Carpéné C; Les F; Cásedas G; Peiro C; Fontaine J; Chaplin A; Mercader J; López V
    Antioxidants (Basel); 2019 Mar; 8(3):. PubMed ID: 30917543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses.
    Kang L; Heng W; Yuan A; Baolin L; Fang H
    Biochimie; 2010 Jul; 92(7):789-96. PubMed ID: 20188786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.